Medical Education

   

Building Clinical Capacity Through Medical Education

  Amyloidosis Africa delivers evidence-based, CPD-accredited medical education to healthcare professionals across Africa, with a strong focus on the early recognition of amyloidosis, standardized diagnostic pathways, and multidisciplinary clinical management. Through targeted education, we aim to close critical knowledge gaps that contribute to delayed diagnosis and inconsistent care for patients with amyloidosis, particularly cardiac amyloidosis.   Medical education represents one of the most effective tools for improving outcomes in rare diseases. By equipping clinicians with practical, context-appropriate knowledge, we strengthen diagnostic confidence and promote earlier, more accurate identification of amyloidosis across diverse healthcare settings.  

Why Medical Education Matters in Africa

  Across many African countries, clinicians receive little or no formal training on amyloidosis during undergraduate or postgraduate education. As a result, healthcare providers may encounter patients with unexplained heart failure, neuropathy, or multisystem symptoms without considering amyloidosis as a potential diagnosis.   Moreover, limited access to subspecialty services and diagnostic tools further compounds this challenge. Without structured and continuous professional development, even experienced clinicians may struggle to recognize early red flags or follow appropriate diagnostic algorithms.   For these reasons, CPD-accredited medical education in Africa plays a critical role in strengthening clinical suspicion, improving diagnostic accuracy, and supporting consistent standards of care across different health systems. Importantly, education must reflect local realities, available resources, and regulatory frameworks to achieve lasting impact.  

Our Educational Approach

  Amyloidosis Africa designs medical education programs that are practical, clinically relevant, and aligned with African healthcare contexts. Rather than focusing solely on theoretical knowledge, our approach emphasizes real-world application and decision-making.   We align all educational activities with:

• Local regulatory and professional requirements
• National CPD accreditation bodies
• Regional clinical practice needs
• International best-practice guidelines

 

What We Teach

  Our medical education content covers the full clinical spectrum of amyloidosis, with particular attention to conditions that are commonly underdiagnosed in Africa.

• Fundamentals of amyloidosis and disease mechanisms
• Cardiac amyloidosis and ATTR-CM recognition
• Differentiating amyloidosis from common heart failure causes
• Diagnostic pathways, including laboratory and imaging approaches
• Multidisciplinary management and referral strategies
• Red flags for hereditary amyloidosis
• Patient-centered communication and follow-up

 

Modes of Delivery

  Online Self-Paced Courses Flexible learning with CPD accreditation, accessible anytime.   Live Webinars Interactive sessions with African and international experts.   Hands-On Training Practical sessions focused on real-world diagnostic skills.   Workshops In-person sessions within hospitals and academic institutions.   Blended Learning Combination of digital and in-person training for stronger impact.  

Supporting Sustainable Clinical Capacity

 

• Training local clinical champions
• Encouraging multidisciplinary participation
• Reinforcing learning through repeated exposure
• Linking education with research and quality improvement

 

Who Our Medical Education Serves

 

• Cardiologists
• General physicians
• Clinical officers and nurses
• Radiologists
• Neurologists
• Pharmacists

 

Moving Forward

  Strengthening medical education is essential to improving amyloidosis care across Africa. Through structured, accredited, and context-aware training, Amyloidosis Africa helps transform awareness into action.   Together, we can build stronger clinical capacity and improve the future of amyloidosis care across Africa.